Cepheid, a leading molecular diagnostics company, and the American Lung Association,the leading organisation working to save lives by improving lung health and preventing lung disease, have partnered to promote tuberculosis-related awareness in the US and the need for improved TB (tuberculosis) diagnostics.
The details of planned programme will be announced at the American Association of Clinical Chemistry and Clinical Lab Expo show in Houston, Texas on July 30.
As part of the programme to highlight the need for increased public awareness and education for TB in the US, Paul Teutul Jr. and his team at Paul Jr. Designs will unveil a brand new creation live during the announcement.
Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.
The American Lung Association is the leading organisation working to save lives by improving lung health and preventing lung disease.